Incyte Corp (FRA:ICY)
€ 49.53 -0.85 (-1.69%) Market Cap: 11.18 Bil Enterprise Value: 7.64 Bil PE Ratio: 16.22 PB Ratio: 2.23 GF Score: 84/100

Incyte Corp at SVB Leerink Global Healthcare (Virtual) Transcript

Feb 17, 2022 / 04:20PM GMT
Release Date Price: €59.28 (+0.24%)
Andrew Scott Berens
SVB Leerink LLC, Research Division - Senior MD of Medical Supplies and Devices & Senior Research Analyst

Good morning, everyone. I'm Andy Berens, senior biotech analyst at SVB Leerink. Thank you for joining us on day 2 of our Global Healthcare Conference.

We are very happy this morning to have with us Incyte Corporation. We have Herve and Christiana and the IR team with us. Thank you for joining us. We appreciate your time and sharing the Incyte story with us.

Herve, why don't we -- yes.

Herve Hoppenot
Incyte Corporation - Chairman, President & CEO

No, no, I was going to say thank you for inviting us and we can talk the way you wish. I was planning to go quickly through a few slides and then going as quickly as we can to Q&A, if it's okay with you.

Andrew Scott Berens;Herve Hoppenot
SVB Leerink LLC, Research Division - Senior MD of Medical Supplies and Devices & Senior Research Analyst;Incyte Corporation - Chairman

Absolutely.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot